Cover image for Vol. 25 Issue S2

Edited By: Jimmie C. Holland and Maggie Watson

Impact Factor: 2.443

ISI Journal Citation Reports © Ranking: 2014: 6/39 (Social Sciences Biomedical); 24/129 (Psychology Multidisciplinary); 29/76 (Psychology); 125/211 (Oncology)

Online ISSN: 1099-1611

Author Guidelines

Online Only
Please note that Psycho-Oncology will be available exclusively online from Volume 22, Number 1, January 2013.

NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement

For additional tools visit Author Services - an enhanced suite of online tools for Wiley Online Library journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.

Author Guidelines

Manuscript Submission

All papers must be submitted via the online system.

Psycho-Oncology operates an online submission and peer review system that allows authors to submit articles online and track their progress via a web interface.

Please read the remainder of these instructions to authors and then click to navigate to the Psycho-Oncology online submission site, ScholarOne Manuscripts (formerly known as Manuscript Central). IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created.

File types. Preferred formats for the text and tables of your manuscript are .doc, .rtf, .ppt, .xls. LaTeX files may be submitted provided that an .eps or .pdf file is provided in addition to the source files. Figures may be provided in .tiff or .eps format.

Please note: This journal does not accept Microsoft Word 2007 documents at this time. Please use Word's "Save As" option to save your document as a .doc file type. If you try to upload a Word 2007 document in ScholarOne Manuscripts you will be prompted to save .docx files as .doc files.

Initial Submission

Non-LaTeX Users: Upload your manuscript files. At this stage, further source files do not need to be uploaded.
LaTeX Users: For reviewing purposes you should upload a single .pdf that you have generated from your source files. You must use the File Designation "Main Document" from the dropdown box.

Revision Submission

Non-LaTeX Users: Editable source files must be uploaded at this stage. Tables must be on separate pages after the reference list, and not be incorporated into the main text. Figures should be uploaded as separate figure files.

LaTeX Users: When submitting your revision you must still upload a single .pdf that you have generated from your now revised source files. You must use the File Designation "Main Document" from the dropdown box. In addition you must upload your TeX source files. For all your source files you must use the File Designation "Supplemental Material not for review". Previous versions of uploaded documents must be deleted. If your manuscript is accepted for publication we will use the files you upload to typeset your article within a totally digital workflow.

Copyright and Permissions

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement

If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:

CTA Terms and Conditions

For authors choosing OnlineOpen

If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

  • Creative Commons Attribution License OAA
  • Creative Commons Attribution Non-Commercial License OAA
  • Creative Commons Attribution Non-Commercial -NoDerivs OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services and visit

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit:

Submission of a manuscript will be held to imply that it contains original unpublished work and is not being submitted for publication elsewhere at the same time. Submitted material will not be returned to the author, unless specifically requested.

Manuscript style. The language of the journal is English. 12-point type in one of the standard fonts: Times, Helvetica, or Courier is preferred. It is not necessary to double-line space your manuscript. There should be a separate title page with full information and another page for an abstract, prior to the Introduction. Tables must be on separate pages after the reference list, and not be incorporated into the main text. Figures should be uploaded as separate figure files.

  • During the submission process you must enter the full title, short title of up to 70 characters and names and affiliations of all authors. Give the full address, including email, telephone and fax, of the author who is to check the proofs.

  • Include the name(s) of any sponsor(s) of the research contained in the paper, along with grant number(s) .

  • Enter an abstract of up to 250 words for all articles. An abstract is a concise summary of the whole paper, not just the conclusions, and is understandable without reference to the rest of the paper. It should contain no citation to other published work. You must submit your abstract according to these headings: objective; methods; results; conclusions.

  • Include up to six keywords which must contain the words cancer and oncology that describe your paper for indexing purposes.

  • Research Articles should not exceed 4000 words (including no more than four figures and/or tables) plus up to 40 references. Review papers of up to 6000 words will be considered, with 80 references - authors should contact the Editors for advice. All papers should use the following headings: Background, Methods (including statistical methods), Results, Conclusions. Word counts should include the title page, abstract, main manuscript, tables and figures, but exclude the references.

  • Qualitative manuscript submissions should usually be based on a minimum of 20 respondents. Authors may contact the Editors if they require further details.

  • When submitting a randomised trial, please complete and supply the CONSORT checklist and include diagram. For systematic reviews or meta-analyses please complete the PRISMA checklist and include flowchart. Please complete and supply AMSTAR for systematic reviews which are narrative reviews not meta-analyses.

  • When you upload your files on the ScholarOne Manuscripts site, please use the file designation 'Supplementary File for Review' for any files which need to be seen by reviewers but should not be included in the final published version of your paper (if accepted for publication). This may include CONSORT checklists, PRISMA flowcharts, or tables and figures which are referred to in the text but which can appear online only as Supporting Information.

Psycho-Oncology publishes Clinical Correspondence. This replaces the previous Brief Reports section. Items submitted as Clinical Correspondence may include:

  1. Feasibility studies
  2. Case studies
  3. Phase I/II clinical trials
  4. Questionnaire development studies
  5. Service Development
  6. Commentary
  7. Novel clinical techniques

The following requirements apply to this section:

  1. Five succinct key points (and no abstract)
  2. Text 1500 words maximum, including the title page, figures and tables, but excluding the references.
  3. Two figures/tables maximum
  4. Ten references maximum
  • Letters to the Editor should not exceed 400 words including a maximum of one reference. No figures or tables. Please note that if Letters to the Editor include a comment on a previously published paper the authors of said paper should be allowed 4 weeks in which to respond. If no response after 4 weeks the Letter will simply be accepted with an Editor's Footnote "The authors of [Title of Paper previously published] offered no comments".

All abbreviations except for SI symbols should be written in full the first time they appear. Generic or clinical names should be used for all compounds: materials and products should be identified. The species of any animals used should be stated precisely. Sources of unusual materials and chemicals, and the manufacturer and model of equipment should be indicated. materials and products should be identified in the text followed by the trade name in brackets.

Reference style. References should be cited in the text by number within square brackets and listed at the end of the paper in the order in which they appear in the text. All references must be complete and accurate. If necessary, cite unpublished or personal work in the text but do not include itin the reference list. Where possible the DOI for the reference should be included at the end of the reference. Online citations should include date of access. References should be listed in the following style:

Decker, CL. Social support and adolescent cancer survivors: A review of the literature. Psycho-Oncology 2007; 16 : 1-11.

Peterson AC, Leffert N. What is special about adolescence? In Psychosocial Disturbances in Young People: Challenges for Prevention, Rutter M (ed.).Cambridge University Press: Cambridge, 1997;3-36.

Illustrations. Upload each figure as a separate file in either .tiff or .eps format, with the figure number and the top of the figure indicated. Compound figures e.g. 1a, b, c should be uploaded as one figure. Tints are not acceptable. Lettering must be of a reasonable size that would still be clearly legible upon reduction, and consistent within each figure and set of figures. Where a key to symbols is required, please include this in the artwork itself, not in the figure legend. All illustrations must be supplied at the correct resolution:

Black and white and colour photos - 300 dpi

Graphs, drawings, etc - 800 dpi preferred; 600 dpi minimum

Combinations of photos and drawings (black and white and colour) - 500 dpi

Tables should be part of the the main document and should be placed after the references. If the table is created in excel the file should be uploaded separately.

Colour Policy. Where colour is necessary to the understanding of the figures, colour illustrations will be reproduced in the journal without charge to the author, at the Editor's discretion.



This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).

Authors of research papers should provide information about funding, a Conflict of Interest statement, details of ethical committee review, and (if the paper is a clinical trial) details of trial registration. All of these declarations should be in the research paper itself, not a covering letter. If authors include named individuals in the Acknowledgements they must confirm that they have approval from those individuals in their covering letter.

Post Acceptance

Further Information. For accepted manuscripts the publisher will supply proofs to the submitting author prior to publication. This stage is to be used only to correct errors that may have been introduced during the production process. Prompt return of the corrected proofs, preferably within two days of receipt, will minimise the risk of the paper being held over to a later issue. Free access to the final PDF offprint of your article will be available via Author Services only. Please therefore sign up for Author Services if you would like to access your article PDF offprint and enjoy the many benefits the service offers.

Authors Resources: Manuscript now accepted for publication?

If so, check out our suite of tools and services for authors and sign up for:

Article Tracking

E-mail Publication Alerts

Personalization Tools

Accepted Articles

'Accepted Articles' have been accepted for publication and undergone full peer review but have not been through the copyediting, typesetting, pagination and proofreading process. Accepted Articles are published online a few days after final acceptance, appear in PDF format only (without the accompanying full-text HTML) and are given a Digital Object Identifier (DOI), which allows them to be cited and tracked. The DOI remains unique to a given article in perpetuity. More information about DOIs can be found online at Given that Accepted Articles are not considered to be final, please note that changes will be made to an article after Accepted Article online publication, which may lead to differences between this version and the Version of Record.

The Accepted Articles service has been designed to ensure the earliest possible circulation of research papers after acceptance.

Accepted articles will be indexed by PubMed; therefore the submitting author must carefully check the names and affiliations of all authors provided in the cover page of the manuscript, as it will not be possible to alter these once a paper is made available online in Accepted Article format. Subsequently the final copyedited and proofed articles will appear either as Early View articles in a matter of weeks or in an issue on Wiley Online Library the link to the article in PubMed will automatically be updated.

Cite EarlyView Articles

To link to an article from the author’s homepage, take the DOI (digital object identifier) and append it to "" as per following example:
DOI 10.1002/hep.20941, becomes

To include the DOI in a citation to an article, simply append it to the reference as in the following example:
Oestreicher, N., The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma, Cancer 10(1) , pp. 2054 - 2062, DOI: 10.1002/cncr.21464.

Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

Note to NIH Grantees

Persuant to NIH mandate, Wiley-Blackwell will post accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see